Le Kremlin-Bicetre, France

Cecile Denis

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Le Kremlin Bicetre Cedex, FR (2013 - 2014)
  • Le Kremlin-bicetre, FR (2020 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cecile Denis

Introduction

Cecile Denis, an accomplished inventor based in Le Kremlin-Bicetre, France, has made significant strides in the field of medical research and therapeutic innovations. With a total of seven patents to her name, Denis has focused her work on developing advanced solutions aimed at improving patient outcomes in the treatment of bleeding disorders such as hemophilia.

Latest Patents

Cecile Denis's latest patents showcase her expertise and commitment to innovative medical solutions. One notable invention is the development of anti-Von Willebrand Factor (VWF) D'D3 single-domain antibodies fused to clotting factors. This invention focuses on isolated single-domain antibodies specifically targeting the VWF D'D3 domain and includes chimeric polypeptides that incorporate blood clotting factors. The therapeutic applications of this invention are poised to enhance the prevention and treatment of hemostatic disorders. Additionally, her work on mutated factor X polypeptides offers promising treatment avenues for hemophilia, featuring a mutated factor X polypeptide with specific amino acid mutations aimed at improving therapeutic efficacy.

Career Highlights

Cecile Denis has had a remarkable career, highlighted by her role at the Institut National de la Santé et de la Recherche Médicale and Université Paris-Saclay. These prestigious institutions have provided her with a platform to embark on groundbreaking research that bridges the gap between laboratory discoveries and clinical applications.

Collaborations

Throughout her career, Cecile Denis has collaborated with esteemed colleagues, including Olivier Christophe and Ghislaine Cherel. These partnerships have further enriched her research endeavors, allowing for the exchange of ideas and expertise that fuel innovation in the field of biomedical research.

Conclusion

Cecile Denis stands out as a leading innovator whose work has the potential to revolutionize the treatment of bleeding disorders. Her patents represent not only her talents as an inventor but also a commitment to improving patient care through innovative therapeutic strategies. As she continues her journey in medical research, Cecile Denis is undoubtedly an inventor to watch in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…